Trimel Pharmaceutica (TRLPF) 0.1000 $TRLPF Zafgen (ZFGN)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Trimel Pharmaceutica (TRLPF) 0.1000 $TRLPF

Zafgen (ZFGN) Presents Favorable New Data on Beloranib
Zacks Equity Research - Zacks Investment Research - Mon Jun 13, 4:45PM CDT
Zafgen Inc. (ZFGN) presented results from the phase IIb ZAF-203 study on beloranib, for the treatment of severe obesity complicated by type II diabetes.
ZFGN: 6.27 (+0.28), JNP: 6.97 (-0.04), ORPN: 1.69 (+0.09)

ARIAD (ARIA) Commences Phase I/II Study on Cancer Drug
Zacks Equity Research - Zacks Investment Research - Wed Jun 01, 4:05PM CDT
ARIAD (ARIA) announced the initiation of a phase I/IIstudy on AP32788 for the treatment of non-small cell lung cancer with specific mutations in EGFR or HER2.
APRI: 0.39 (-0.01), JNP: 6.97 (-0.04), ARIA: 7.49 (+0.10)

Dipexium Pharmaceuticals (DPRX) Jumps: Stock Rises 7.5%
Zacks Equity Research - Zacks Investment Research - Fri Apr 29, 7:40AM CDT
Dipexium Pharmaceuticals, Inc. (DPRX) saw its shares rise above 7% in the last trading session.
DPRX: 9.89 (-0.02)

Loxo Oncology (LOXO) Looks Good: Stock Adds 7% in Session
Zacks Equity Research - Zacks Investment Research - Fri Apr 01, 7:40AM CDT
Loxo Oncology, Inc. (LOXO) saw its shares rise 7% in the last trading session.
LOXO: 23.16 (-0.02)

Stock Market Roundup: Apple Rumors, VRX Crashes
Ryan McQueeney - Zacks Investment Research - Tue Mar 15, 4:04PM CDT
All the latest stock market news for Tuesday, March 15.
EVA: 23.84 (+1.08), VRX: 20.44 (+0.30), AVP: 3.96 (+0.18), PRMW: 11.49 (-0.32), NSP: 76.66 (-0.57), NAP: 11.87 (+0.10), AAPL: 95.89 (+0.29)

Trimel Announces Corporate Name Change to Acerus Pharmaceuticals Corporation
BusinessWire - Tue Sep 08, 10:26AM CDT
Trimel Pharmaceuticals Corporation (TSX:TRL) today announced that it has changed its corporate name to Acerus Pharmaceuticals Corporation ("Acerus", pronounced ay-SAIR-us), effective immediately.
TRL.TO: 0.43 (-0.02)

Trimel Commends FDA's Approval of the First Treatment for Female Sexual Dysfunction
BusinessWire - Wed Aug 19, 4:00PM CDT
Trimel Pharmaceuticals Corporation (TSX:TRL) today communicated its support of the U.S. Food and Drug Administration's (FDA) decision to approve ADDYI(TM) (flibanserin; developed by Sprout Pharmaceuticals), the first treatment option for female sexual dysfunction (FSD). Trimel is currently developing TEFINA(TM), a 'use as required', low-dose nasal testosterone gel treatment for female orgasmic disorder, a subset of FSD.
TRL.TO: 0.43 (-0.02)

Trimel Announces Second Quarter 2015 Financial Results and Highlights
BusinessWire - Wed Aug 05, 6:00AM CDT
--Adjusted EBITDA(1) of ($0.4) million for Q2 2015 versus ($0.2) million in Q1 2015
TRL.TO: 0.43 (-0.02)

Trimel to Report Second Quarter 2015 Results and Host Conference Call to Update Investors
BusinessWire - Wed Jul 29, 6:00AM CDT
Trimel Pharmaceuticals Corporation (TSX:TRL) will report its second quarter financial results for the period ended June 30, 2015 on Wednesday, August 5, 2015 before the market opens.
TRL.TO: 0.43 (-0.02)

Trimel Announces Change to Management Team
BusinessWire - Mon Jul 13, 6:00AM CDT
Trimel Pharmaceuticals Corporation (TSX:TRL) today announced a change to its management team. Dr. Michael Bumby will be appointed Chief Financial Officer, succeeding Mr. Kenneth Howling, who will be leaving the Company to pursue other opportunities. Dr. Bumby will join Trimel as of August 3, 2015, however Mr. Howling will remain in his role until the end of August to ensure a smooth transition.
TRL.TO: 0.43 (-0.02)

Trimel Announces Voting Results for 2015 Annual General and Special Shareholder's Meeting
BusinessWire - Fri Jun 26, 3:30PM CDT
Trimel Pharmaceuticals Corporation (TSX:TRL) today announced the voting results from its annual general and special meeting held on June 26, 2015. The total number of shares represented in person or by proxy at the meeting was 120,951,218, representing 60.21% of Trimel's total issued and outstanding shares.
TRL.TO: 0.43 (-0.02)

Trimel Confirms Next FDA Meeting on TEFINA(TM)
BusinessWire - Thu Jun 11, 6:00AM CDT
Trimel Pharmaceuticals Corporation (TSX:TRL) today reported that it has scheduled a consultation meeting with the U.S. Food and Drug Administration (FDA) to be held in August to discuss TEFINA(TM), a "use as required" nasal testosterone gel in development for female orgasmic disorder. Building on the FDA feedback received earlier this year, the objective will be to review and solicit comments on the draft protocol for a subsequent study in the TEFINA(TM) clinical program.
TRL.TO: 0.43 (-0.02)

Trimel to Present at the JMP Securities Life Sciences Conference 2015
BusinessWire - Mon Jun 08, 6:00AM CDT
Trimel Pharmaceuticals Corporation (TSX:TRL) today announced that management is scheduled to present an overview of the Company at the JMP Securities Life Sciences Conference 2015 at the St. Regis New York on June 24, 2015 at 2:30 p.m. Eastern Time.
TRL.TO: 0.43 (-0.02)

Trimel Announces First Quarter 2015 Financial Results and Highlights
BusinessWire - Wed May 06, 6:00AM CDT
Trimel Pharmaceuticals Corporation (TSX:TRL) today reported its financial results for the three month period ended March 31, 2015, and provided an overview of its corporate highlights. Unless otherwise noted, all dollar amounts shown in this press release are in U.S. dollars.
ENDP: 16.98 (+1.39), ENL.TO: 21.99 (+1.27), TRL.TO: 0.43 (-0.02)

Trimel to Report First Quarter 2015 Results and Host Conference Call to Update Investors
BusinessWire - Thu Apr 30, 6:00AM CDT
Trimel Pharmaceuticals Corporation (TSX:TRL) will report its first quarter financial results for the period ended March 31, 2015 on Wednesday, May 6, 2015 before the market opens.
TRL.TO: 0.43 (-0.02)

Trimel to Present at the 2015 Bloom Burton & Co. Healthcare Investor Conference
BusinessWire - Mon Apr 13, 6:22AM CDT
Trimel Pharmaceuticals Corporation (TSX:TRL) today announced that management is scheduled to present an overview of the Company at the 2015 Bloom Burton & Co. Healthcare Investor Conference at the Sheraton Centre Toronto Hotel on May 4, 2015 at 3:00 p.m. Eastern Time.
TRL.TO: 0.43 (-0.02)

Trimel Announces Natesto(TM) Abstract Presentation at the 2015 Endocrine Society Annual Meeting
BusinessWire - Mon Mar 09, 6:00AM CDT
Trimel Pharmaceuticals Corporation (TSX:TRL) today announced that an abstract highlighting the Phase III study results and therapeutic potential of NATESTO(TM), a product utilizing Trimel's licensed nasal gel technology, was featured at the Endocrine Society 97th Annual Meeting in San Diego, California on Saturday, March 7, 2015.
ENDP: 16.98 (+1.39), ENL.TO: 21.99 (+1.27), TRL.TO: 0.43 (-0.02)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 607

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 731

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 666

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 445

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
AutoShop Answers Extends 2027 Training Into Fridays

Updated Category News Views 60

A repair bay can hum all day while the back office quietly bleeds profit. That unglamorous reality is why AutoShop Answers adding nine Friday specialty classes to its 2027 Key2Key Weekend calendar deserves a closer look. This is not a new tool chest or some vague motivational roadshow; it is an attempt to give independent shop owners an extra day to work on the pieces...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 385

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 303

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading

Top 5 Most Recently Viewed Articles

T-Mobile's Starlink Satellite Service Beta is Now Open for Signup

Updated Category News Views 270

T-Mobile Introduces Registration for Starlink Beta Program T-Mobile US, Inc. (NASDAQ: TMUS) has recently opened registrations for its much-anticipated beta program for Starlink, a direct-to-cell satellite service aimed at enhancing connectivity. This service promises to bridge the gaps in network coverage across vast areas of the United States, specifically targeting dead...

Continue Reading
WAVJA's Innovative Energy System Set to Change Indoor Power

Updated Category News Views 342

WAVJA's Photon Energy System Overview The energy landscape is undergoing significant changes, and WAVJA is at the forefront with its groundbreaking Photon Energy System (PES). This U.S.-based innovation is not just about powering homes; it's revolutionizing how we think about renewable sources of energy. In a time where climate challenges are prevalent, PES transforms the...

Continue Reading
Kipling Unveils New Collections at Exclusive London Event

Updated Category News Views 333

Kipling Launches Exciting New Collection in London Recently, Kipling captivated the fashion world by hosting an innovative and exclusive event in London. This gathering celebrated the unveiling of their latest collection, G.rilla Girlz, and brought a nostalgic touch by showcasing some of the brand's most iconic designs. A Night to Remember at Village Underground The event...

Continue Reading
Transforming TV Experiences: Cerence Renews Voice Interaction with LG

Updated Category News Views 159

Enhancing LG TVs with Conversational AI In a significant leap towards improved user experience, Cerence Inc. (NASDAQ: CRNC) has partnered with LG Electronics Inc. to integrate advanced voice interaction technology into LG's global television lineup. This innovative collaboration harnesses Cerence’s cloud-based neural text-to-speech (TTS) technology, enriching the way...

Continue Reading
Exciting Prize Opportunities as Bybit Welcomes New Traders to WSOT

Updated Category News Views 40

Bybit Enhances Participation Incentives for WSOT 2024 Bybit, a leading cryptocurrency exchange, is thrilled to announce an enticing prize opportunity aimed at encouraging last-minute participants in the World Series of Trading (WSOT) 2024. This newly implemented initiative allows late entrants to access a dedicated prize pool of 100,000 USDT. This bonus pool is designed...

Continue Reading